Pharmacokinetics of Adrenaline After Administration of ARS -1 in Subjects With Upper Respiratory Tract Infection
Clinical trial NCT04930900 · COMPLETED
Trial details
- NCT number
- NCT04930900
- Sponsor
- ARS Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-09
- Primary completion
- 2022-03-31
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.